SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-000982
Filing Date
2020-01-14
Accepted
2020-01-14 16:04:13
Documents
2
Group Members
ALPHA BIOLABS, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13D sc13d0120a6alpha_oncosec.htm SC 13D/A 38628
2 BINDING TERM SHEET DELIVERED BY ALPHA HOLDINGS, INC. TO THE BOARD OF DIRECTORS O sc13d0120a6alphaex99-1.htm EX-99.1 38591
  Complete submission text file 0001213900-20-000982.txt   78752
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Subject) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-86770 | Film No.: 20526090
SIC: 2834 Pharmaceutical Preparations

Mailing Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016
Business Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016 011-8225178841
Alpha Holdings, Inc. (Filed by) CIK: 0001755469 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A